Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls

Pancreatic adenocarcinoma (PaC) is one of most difficult tumors to treat. Much of this is attributed to the late diagnosis. To identify biomarkers for early detection, we examined DNA methylation differences in leukocyte DNA between PaC cases and controls in a two-phase study. In phase I, we measure...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pedersen, Katrina S., Bamlet, William R., Oberg, Ann L., de Andrade, Mariza, Matsumoto, Martha E., Tang, Hui, Thibodeau, Stephen N., Petersen, Gloria M., Wang, Liang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2011
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3063802/
https://ncbi.nlm.nih.gov/pubmed/21455317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0018223
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak